Strategy
With the Part D program now in its fourth year, prescription drug plans are at an important crossroads.
With the Part D program now in its fourth year, prescription drug plans are at an important crossroads. With a limited ability to impact long term clinical outcomes, PDPs must perfect their administration of the product, as there is virtually no margin for error in today’s highly competitive bidding environment.
Basic administrative challenges, such as enrollment, are magnified for these plans. And the market is by no means stable--- in recent enrollment periods, some sponsors have seen record-breaking enrollment, others, similarly dramatic contraction.
For these plans already in Medicare Advantage, GHG can help your plan define a strategy to convert your PDP members into MA-PD members, where you can better deliver on the promise of enhanced quality and outcomes. For those who wish to remain Part D sponsors only, we will focus on product pricing and positioning, member retention and execution of your operational plan--- especially in the enrollment department. No matter the size of the plan, we judge our success by yours.
To speak directly with one of our industry leaders, please contact us at ghg@gormanhealthgroup.com.

